Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes

10.1161/01.CIR.30.1.17

10.1007/BF01778848

10.1161/01.CIR.44.1.130

10.1016/0002-8703(86)90010-4

10.1056/NEJM199407073310108

10.1016/0735-1097(96)00121-0

10.1161/01.CIR.94.7.1613

10.1016/S0140-6736(96)02149-6

10.1136/hrt.48.3.213

10.1016/S0735-1097(96)00377-4

10.1161/01.RES.72.3.631

10.1161/01.RES.79.3.474

10.1161/01.CIR.86.5.1376

10.1136/hrt.63.6.342

10.1016/0002-8703(84)90081-4

10.1001/jama.1993.03510210076031

10.1093/cvr/27.12.2186

10.1111/j.1540-8159.1998.tb00150.x

10.1136/hrt.32.1.57

10.1002/clc.4960170410

10.1136/pgmj.68.798.289

10.1016/0735-1097(95)00286-5

Choy AMJ, 1996, Increased sensitivity to QT prolonging drug therapy immediately after cardioversion to sinus rhythm, Circulation, 94, 1202

10.1161/01.RES.75.5.879

Turgeon J, 1994, Diuretics potentiate monophasic action potential prolonging effects of class III antiarrhythmic drugs in isolated guinea pig hearts (abstract), Circulation, 90

10.1016/0002-9149(87)90634-5

10.1161/01.CIR.87.6.1866

10.1161/01.RES.73.5.857

10.1161/01.RES.72.1.75

Sanguinetti MC, 1990, Two components of cardiac delayed rectifier K+ current: Differential sensitivity to block by class III antiarrhythmic agents, J Gen Physiol, 96, 195, 10.1085/jgp.96.1.195

10.1001/jama.1993.03500120070028

10.1161/01.CIR.94.4.817

Carlsson L, 1997, Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro implications for proarrhythmic potential, J Pharmacol Exp Ther, 282, 220

Lee KS., 1992, Ibutilide, a new compound with potent class III antiarrhythmic activity, activates a slow inward Na+ current in guinea pig ventricular cells, J Pharmacol Exp Ther, 262, 99

10.1161/01.CIR.91.6.1799

10.1161/01.CIR.93.3.407

Yang T, 1997, Discordance between IKr block and torsades de pointes, Circulation, 96, 1554

10.1016/0092-8674(95)90340-2

10.1093/cvr/27.12.2186

10.1001/jama.1990.03450210088038

10.1056/NEJM199607253350416

Hohnloser SH, 1992, Incidence, type, and dose‐dependence of proarrhythmic events during sotalol therapy in patients treated for sustained VT/VF, PACE, 15, 551

Rautaharju PM, 1992, Sex differences in the evolution of the electrocardiographic QT interval with age, Can J Cardiol, 8, 690

10.1161/01.RES.78.2.262

10.1016/1050-1738(93)90016-Y

10.1161/01.CIR.94.8.1996

Napolitano C, 1997, Identification of a long QT syndrome molecular defect in drug‐induced torsades de pointes, Circulation, 96, I211

Schultz‐Bahr E, 1997, Do mutations in cardiac ion channel genes predispose to drug‐induced (acquired) long QT syndrome, Circulation, 96, I‐211